This compound is a benzimidazole derivative featuring a difluorinated chromane ether side chain. It is primarily utilized as a research reagent in pharmaceutical development, with its structure suggesting potential for studying receptor interactions or biochemical pathways.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 2351939-46-1
7-[(5,7-Difluorochroman-4-yl)oxy]-2-methyl-1H-benzo[d]imidazole-5-carboxylic Acid
Pharmaceutical intermediate
Tegoprazan
potassium-competitive acid blocker
(4R)-Tegoprazan
active pharmaceutical ingredient
Loratadine N-Oxide
pharmaceutical research compound
4-(4-Cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxamide
pharmaceutical research compound
1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride
pharmaceutical research compound
Benzoic acid, 4-(2-(octyloxy)benzamido)-, 2-(diethylamino)ethyl ester hydrochloride
pharmaceutical research compound
N-isopropyl-2-nitrobenzenesulfonamide
research compound
7-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-N,2-dimethyl-3H-benzimidazole-5-carboxamide
XSFQYWLWWMLNHM-UHFFFAOYSA-N
CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)NC